Pfizer Inc. (PFE)
After hours:
| Previous close | 28.72 |
| Open | 28.72 |
| Bid | 29.02 x 3000 |
| Ask | 28.95 x 2900 |
| Day's range | 28.67 - 29.05 |
| 52-week range | 25.20 - 36.29 |
| Volume | |
| Avg. volume | 32,225,652 |
| Market cap | 164.391B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings date | 29 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | 1.68 (5.79%) |
| Ex-dividend date | 26 Jul 2024 |
| 1y target est | 33.01 |
Insider MonkeyPfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Pfizer. Inc. (NYSE:PFE) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
Investor's Business DailyWhy IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
Alnylam stock tumbled Friday after the company's Pfizer-rivaling heart disease treatment lagged expectations in a lengthy study.
- Associated Press Finance
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. Already, Pfizer and Moderna are shipping shots modified to better match more recent strains of the ever-evolving coronavirus. Friday, the Food and Drug Administration gave the OK to the updated Novavax formula, too — and those shots are open to anyone 12 and older.
